A Novel Cancer Stemness-Related Signature for Predicting Prognosis in Patients with Colon Adenocarcinoma

Figure 4

Internal and external validation of a novel cancer stemness-related prognostic signature in COAD patients. (a, b) The survival analysis between the high- and low-risk groups and corresponding area under the ROC curve in the train cohort. The survival analysis between the high- and low-risk groups in the (c) test cohort, (d) whole GSE39582 cohort, (e) TCGA cohort, and (f) GSE17538 cohort.

(a)

(b)

(c)

(d)

(e)

(f)